Impact Factor
2.05
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.60
92 total citations
h5-index
10
h5 depth signal
Cited share
32.5%
50 of 154
Total citations
92
Citation footprint
Metric signal
0.47
External metric anchor
Self-citation
1.1%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
436
Canada
27
India
24
Australia
18
Egypt
10
Citing Fields of Research
Anesthetic & Pain Medicine
545
Substance Abuse
281
Pharmacology & Toxicology
20
Musculoskeletal Disorders
17
Health Education & Remote Healthcare
15
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,244
Articles tracked across the journal lifetime
Indexed publication set
154
50 cited publications
Last 12 months
58
9.7 publications/month
Open access share
17.2%
10 OA publications in the last year
Leading citing country
United States
436 citing publications
Leading citing field
Anesthetic & Pain Medicine
545 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Mar./Apr. 2005-
v1n1, Mar./Apr. 2005-
Research Focus & Classification
Indexed Subjects
Anesthetic & Pain Medicine
Substance Abuse
Broad Categories
Drug Therapy
Neurology
Psychophysiology
Substance-Related Disorders
Substance Abuse
Anesthetic & Pain Medicine
MeSH Descriptors
Analgesics, Opioid
Narcotics
Opioid-Related Disorders
Pain
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.5055/jom.1008
Open DOI
Assessment of a standardized pain management protocol for adult patients with sickle cell disease
Objective: To evaluate the impact of a standardized pain management protocol on prescribing practices for opioids, nonopioid therapies, and disease-modifying agents among adult patients with sickle cell disease (SCD) in an outpatient set...
02
DOI 10.5055/jom.0987
Open DOI
Digital twins for personalized management of opioid use disorder: A future outlook
Introduction: The opioid crisis, affecting over 16 million individuals globally and causing approximately 450,000 deaths annually, underscores the urgent need for personalized treatment approaches for opioid use disorder (OUD). Current t...
03
DOI 10.5055/jom.1012
Open DOI
Rationales for abrupt discontinuation of long-term opioid therapy for chronic pain: A thematic analysis
Objective: Evidence and clinical guidelines document serious negative health consequences of abrupt discontinuation of long-term opioid therapy (LTOT). Nevertheless, recent studies suggest that up to 80 percent of patients with chronic p...
04
DOI 10.5055/jom.1005
Open DOI
OUR crisis: Evolution of a third-year medical student opioid epidemic-themed inter-clerkship week to reflect the landscape of pain and addiction care
Objective: A week-long themed interclerkship curricular experience was designed to reframe THE Opioid Epidemic as “OUR Opioid Epidemic,” humanize and normalize opioid use disorder and pain, and motivate a shift in attitudes, knowledge, c...
05
DOI 10.5055/jom.0996
Open DOI
Comparison of long-term outcomes between opioid-free and opioid-based anesthesia in head and neck cancer surgeries: A pilot study
Background, aim, and objective: Literature is replete with studies evaluating opioid-sparing strategies in head and neck cancer (HNC) surgeries; however, no study has attempted opioid-free anesthesia (OFA). Various long-term outcomes hav...
06
DOI 10.5055/jom.0934
Open DOI
Impact of an addiction medicine consult service on medications for opioid use disorder initiation in hospitalized patients
Objective: The number of overdose deaths rose by 60 percent between 2019 and 2021. Medications for opioid use disorder (MOUD) have been associated with reduced overdoses and opioid-related hospitalizations. Hospital addiction medicine co...
07
DOI 10.5055/jom.0945
Open DOI
Opioid-free blended analgesia in patients undergoing thoracic surgery: Preliminary results
Objective: Thoracic surgery is recognized as one of the most painful surgical procedures. Opioids represent the most effective analgesic drug for pain management after these procedures. However, opioid use is related to side effects such...
08
DOI 10.5055/jom.0984
Open DOI
The critical role of maxillofacial surgeons in pain prevention and opioid consumption reduction
Objectives: Managing pain in oral and maxillofacial surgery (OMS) poses significant challenges due to the intricate nature of the procedures and extensive tissue manipulation. While opioids are often utilized for their strong analgesic e...
09
DOI 10.5055/jom.0986
Open DOI
Global cannabis regulations: Current scenario and the way ahead
Cannabis sativa is commonly known as cannabis or marijuana. It is a psychoactive drug. It has been in use for thousands of years for its medicinal and recreational properties. This article explores the regulatory frameworks governing can...
10
DOI 10.5055/jom.0972
Open DOI
Cancer pain management with concurrent complex gastrointestinal pathology: A case for sublingual buprenorphine
A 35-year-old male with a complex gastrointestinal history and metastatic intrahepatic cholangiocarcinoma was hospitalized with intractable cancer-associated pain, unrelieved by oral opioids at escalating doses. Transdermal options were ...
Bibliographical & Catalog Notes
Also issued online.
v.1, no. 1 (Jan. 2005)20070104 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper